NONCLASSICAL ANTIMETABOLITES. XVI. THE BRIDGE PRINCIPLE OF  SPECIFICITY WITH ACTIVE SITE-DIRECTED IRREVERSIBLE INHIBITORS. VII. DETECTION OF DIFFERENCES IN SPECIFICITY OF ENZYMIC NUCLEOPHILIC SITES BY THE MALEAMYL GROUP.
D000963:Antimetabolites; D020134:Catalytic Domain; D004791:Enzyme Inhibitors; D007770:L-Lactate Dehydrogenase; D010088:Oxidoreductases; D010600:Pharmacology; D012106:Research; D020156:Salicylic Acid
D000963:Antimetabolites; D004791:Enzyme Inhibitors; D010088:Oxidoreductases; D007770:L-Lactate Dehydrogenase; D020156:Salicylic Acid
ANTIMETABOLITES; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; LACTATE DEHYDROGENASE; OXIDOREDUCTASES; PHARMACOLOGY; SALICYLIC ACID